US-based biotechnology company Rallybio is discontinuing its RLYB212 program for...
The U.S. may soon impose significant tariffs on pharmaceutical imports, accordin...
Through its licensing deal with Eli Lilly, Sangamo Therapeutics received $18 mil...
The French biotech company Oncodesign Precision Medicine has been forced to tigh...
As research institutions throughout the United States grapple with increasing in...
Roche has disclosed preliminary findings regarding its investigational Alzheimer...
The US Food and Drug Administration has sent a second detailed reaction letter t...
The latest Phase 3 trial results for Immunovant’s batoclimab drug showed achieve...
Opko Health and Entera Bio have formally announced their collaboration as the bi...
Taiho Pharmaceutical has paid Otsuka $400 million in upfront purchase of the Ara...
A young patient diagnosed with Duchenne muscular dystrophy has passed away follo...
GSK’s ViiV Healthcare has disclosed clinical data about three prospective long-a...
Hologen AI has pledged up to $430 million through a strategic partnership to sup...
After almost a decade of contending with bankruptcy filings and opioid settlemen...
Roche has committed to an initial payment of $1.65 billion to enhance its growin...
Johnson & Johnson has contributed to the ongoing issues surrounding opioids. Mon...
